Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Rolland-Debord, S. Fry, C. Langlois, B. Aguilaniu, A. Bellocq, S. Dominique, A. Delobbe, G. François, K. Yasunaga, A. Tazi, B. Wallaert (Lille, France). Cardiorespiratory responses to incremental exercise in patients with pulmonary Langerhans' cell histiocytosis. Eur Respir J 2014; 44: Suppl. 58, 3223

Member's Comments

No comment yet.

Related content which might interest you: Six-minute-walk test parameters in the prognostic evaluation of fibrotic lung diseases Source: International Congress 2014 – ILDs 4 Year: 2014 Does hypoxemia increases risks in hospitalized patients with diffuse interstitial lung disease? Source: International Congress 2014 – ILDs 6 Year: 2014 Clinical data, lung function and cardiopulmonary exercise testing in CPFE (combined pulmonary fibrosis with emphysema). Results of a cohort of 20 patients Source: International Congress 2014 – ILDs 6 Year: 2014 Pregnancy course in patients with interstitial lung diseases Source: International Congress 2014 – ILDs 5 Year: 2014 The role of CCR2+CD4+T cells in lung fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Evolution of an interstitial lung disease MDT: 5.5 years of data Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Lung 18F-FDG uptake correlates with lung function alteration in patients with IPF Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations Source: International Congress 2014 – ILDs 6 Year: 2014 Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014 Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH) Source: International Congress 2015 – IIPs: orphan Year: 2015 Change of A549 cells characteristics upon stimulation with BALF of patients with interstitial lung diseases Source: International Congress 2014 – ILDs 4 Year: 2014 Live patient and partner survey on pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Beneficial effect of azithromycin in children with diffuse parenchymal lung disease Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Pulmonary hemodynamics and gasometric parameters associated with exercise induced oxygen desaturation in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 3 Year: 2014 Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 2 Year: 2014 Mindfulness-based stress reduction in patients with interstitial lung disease: A pilot study Source: International Congress 2014 – ILDs 3 Year: 2014 Morality predictors in acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 6 Year: 2014 Influence of pregnancy on pulmonary function in women with pulmonary Langerhans cell histiocytosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Cardiopulmonary exercise testing in interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary? Source: International Congress 2014 – ILDs 4 Year: 2014